Correlation Between Amicus Therapeutics and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amicus Therapeutics and Allogene Therapeutics, you can compare the effects of market volatilities on Amicus Therapeutics and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Allogene Therapeutics.
Diversification Opportunities for Amicus Therapeutics and Allogene Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Amicus and Allogene is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Amicus Therapeutics and Allogene Therapeutics
Given the investment horizon of 90 days Amicus Therapeutics is expected to generate 0.35 times more return on investment than Allogene Therapeutics. However, Amicus Therapeutics is 2.82 times less risky than Allogene Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Allogene Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 979.00 in Amicus Therapeutics on October 25, 2024 and sell it today you would lose (25.00) from holding Amicus Therapeutics or give up 2.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amicus Therapeutics vs. Allogene Therapeutics
Performance |
| Timeline |
| Amicus Therapeutics |
| Allogene Therapeutics |
Amicus Therapeutics and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amicus Therapeutics and Allogene Therapeutics
The main advantage of trading using opposite Amicus Therapeutics and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.| Amicus Therapeutics vs. Incyte | Amicus Therapeutics vs. Denali Therapeutics | Amicus Therapeutics vs. argenx NV ADR | Amicus Therapeutics vs. Harmony Biosciences Holdings |
| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |